A Simple Kit for the Good-Manufacturing-Practice Production of [68Ga]Ga-EDTA
Abstract
:1. Introduction
2. Results
2.1. EDTA Kits
2.1.1. EDTA-Kit Composition
2.1.2. EDTA Kit Validation
2.1.3. Na2EDTA Dihydrate Content Determination in EDTA Kits
2.1.4. Buffer Capacity: Labelling Process’ Robustness
2.2. [68Ga]Ga-EDTA
2.2.1. EDTA Kit Labelling with 68Ga
2.2.2. Paper Chromatography of [68Ga]Ga-EDTA
3. Discussion
3.1. Determination of EDTA Kit Composition
3.1.1. Amount of Na2EDTA Dihydrate
3.1.2. Amount of NaOAc Trihydrate
3.1.3. Amount of NaOH
3.2. Na2EDTA Dihydrate Concentration Determination as a Quality Control of EDTA Kit
3.3. Development of Labeling Method
3.4. Development of Chromatographic Method for [68Ga]Ga-EDTA
- Generator eluate consisting of [68Ga]GaCl3 was analyzed using Whatman paper, showing that radioactivity developed to the eluent front only as [68Ga]Ga-EDTA. Therefore, if free [68Ga]Ga3+ exists, it cannot be separated from the intended product.
- The 68Ge/68Ga-generator was eluted into a kit prepared without EDTA (analogous to the production of [68Ga]Ga-EDTA). On the Whatman paper, the product stayed at Rf = 0 showing that, if EDTA is not present, free [68Ga]Ga3+ does not exist in the solution.
- The intended [68Ga]Ga-EDTA product analyzed using HPLC provided a single clear peak at Rt = 5.9 min. However, the eluate solution and the kit without EDTA did not produce signals on the HPLC chromatograms, thus indicating that 68Ga was trapped on the HPLC column in both cases.
4. Materials and Methods
4.1. EDTA kit Production
4.2. EDTA Kit Quality Control
4.3. [68Ga]Ga-EDTA Production
4.4. [68Ga]Ga-EDTA Quality Control
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Sample Availability
References
- Nudat. NUDAT. Available online: https://www.nndc.bnl.gov/nudat2/reCenter.jsp?z=31&n=37 (accessed on 9 October 2022).
- Velikyan, I. 68Ga-Based Radiopharmaceuticals: Production and Application Relationship. Molecules 2015, 20, 12913–12943. [Google Scholar] [CrossRef] [PubMed]
- Pozzilli, C.; Bernardi, S.; Mansi, L.; Picozzi, P.; Iannotti, F.; Alfano, B.; Bozzao, L.; Lenzi, G.L.; Salvatore, M.; Conforti, P. Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J. Neurol. Neurosurg. Psychiatry 1988, 51, 1058–1062. [Google Scholar] [CrossRef] [PubMed]
- Gottschalk, A.; Anger, H. The sensitivity of the positron scintillation camera for detecting simulated brain tumors with gallium 68-EDTA. Am. J. Roentgenol. Radium Therapy Nucl. Med. 1964, 92, 174–176. [Google Scholar]
- Roesch, F.; Riss, P.J. The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry. Curr. Top. Med. Chem. 2010, 10, 1633–1668. [Google Scholar] [CrossRef] [PubMed]
- Banerjee, S.R.; Pomper, M.G. Clinical applications of Gallium-68. Appl. Radiat. Isot. 2013, 76, 2–13. [Google Scholar] [CrossRef] [PubMed]
- Van Leeuwen, P.; Emmett, L.; Hruby, G.; Kneebone, A.; Stricker, P. 548 68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. Eur. Urol. Suppl. 2016, 15, e548. [Google Scholar] [CrossRef]
- Yamashita, M.; Inaba, T.; Kawase, Y.; Iiorii, H.; Wakita, K.; Fujii, R.; Nakahashi, H. Quantitative measurement of renal function using Ga-68-EDTA. Tohoku J. Exp. Med. 1988, 155, 207–208. [Google Scholar] [CrossRef] [PubMed]
- Hofman, M.S.; Hicks, R.J. Gallium-68 EDTA PET/CT for Renal Imaging. 68ga-PET Curr. Status 2016, 46, 448–461. [Google Scholar] [CrossRef]
- Ding, Y.; Liu, Y.; Zhang, L.; Deng, Y.; Chen, H.; Lan, X.; Jiang, D.; Cao, W. Quantitative assessment of renal functions using 68Ga-EDTA dynamic PET imaging in renal injury in mice of different origins. Front. Med. 2023, 10, 1143473. [Google Scholar] [CrossRef]
- Fontana, A.O.; Melo, M.G.; Allenbach, G.; Georgantas, C.; Wang, R.; Braissant, O.; Barbey, F.; Prior, J.O.; Ballhausen, D.; Viertl, D. The use of 68Ga-EDTA PET allows detecting progressive decline of renal function in rats. Am. J. Nucl. Med. Mol. Imaging 2021, 11, 519–528. [Google Scholar]
- Hacht, B. Gallium(III) Ion Hydrolysis under Physiological Conditions. Bull. Korean Chem. Soc. 2008, 29, 372. [Google Scholar]
- Bauwens, M.; Chekol, R.; Vanbilloen, H.; Bormans, G.; Verbruggen, A. Optimal buffer choice of the radiosynthesis of 68Ga–Dotatoc for clinical application. Nucl. Med. Commun. 2010, 31, 753–758. [Google Scholar] [CrossRef] [PubMed]
- Heydari, R.; Shamsipur, M.; Naleini, N. Simultaneous Determination of EDTA, Sorbic Acid, and Diclofenac Sodium in Pharmaceutical Preparations Using High-Performance Liquid Chromatography. AAPS PharmSciTech 2013, 14, 764–769. [Google Scholar] [CrossRef] [PubMed]
- Narola, B.; Singh, A.; Mitra, M.; Santhakumar, P.; Chandrashekhar, T. A Validated Reverse Phase HPLC Method for the Determination of Disodium EDTA in Meropenem Drug Substance with UV-Detection using Precolumn Derivatization Technique. Anal. Chem. Insights 2011, 6, 7–14. [Google Scholar] [CrossRef] [PubMed]
- Bergers, P.J.M.; De Groot, A.C. The Analysis of EDTA in Water by HPLC. Water Res. 1994, 28, 639–642. [Google Scholar] [CrossRef]
- Gillings, N.; Todde, S.; Behe, M.; Decristoforo, C.; Elsinga, P.; Ferrari, V.; Hjelstuen, O.; Peitl, P.K.; Koziorowski, J.; Laverman, P.; et al. EANM guideline on the validation of analytical methods for radiopharmaceuticals. EJNMMI Radiopharm. Chem. 2020, 5, 7–29. [Google Scholar] [CrossRef] [PubMed]
- Gündel, D.; Pohle, U.; Prell, E.; Odparlik, A.; Thews, O. Assessing Glomerular Filtration in Small Animals Using [68Ga]DTPA and [68Ga]EDTA with PET Imaging. Mol. Imaging Biol. 2017, 20, 457–464. [Google Scholar] [CrossRef]
- ENDRATE Package Insert. Available online: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=290c3e9c-c0c6-440a-1a9c-46e3e2b07a77&type=display (accessed on 10 August 2022).
- ANSTRO (Chromium [51Cr]CrEDTA package inlet). Available online: https://www.ansto.gov.au/sites/default/files/2020-05/Chromium-51Cr%20Edetate%20Injection%20BP%202020.pdf (accessed on 10 August 2022).
- European Pharmacopeia. European Pharmacopeia. European Pharmacopeia Monograph “Gallium (68Ga) PSMA-11 Innjection” (04/2021:3044). In European Pharmacopeia, 10th ed.; European Pharmacopoeia: Strasbourg, France, 2020. [Google Scholar]
- Ali, M.; Hsieh, W.; Tsopelas, C. An improved assay for68Ga-hydroxide in68Ga-DOTATATE formulations intended for neuroendocrine tumour imaging. J. Label. Compd. Radiopharm. 2015, 58, 383–389. [Google Scholar] [CrossRef]
- Hnatowich, D.J. A method for the preparation and quality control of 68Ga radiopharmaceuticals. J. Nucl. Med. 1975, 16, 764–768. [Google Scholar]
- Brom, M.; Franssen, G.M.; Joosten, L.; Gotthardt, M.; Boerman, O.C. The effect of purification of Ga-68-labeled exendin on in vivo distribution. EJNMMI Res. 2016, 6, 65. [Google Scholar] [CrossRef]
- Larenkov, A.A.; Ya Maruk, A. Radiochemical Purity of 68Ga-BCA-Peptides: Separation of All 68Ga species with a Single iTLC Strip. Int. J. Chem. Mol. Nucl. Mater. Metall. Eng. 2016, 10, 1212. [Google Scholar]
- Larenkov, A.; Rakhimov, M.; Lunyova, K.; Klementyeva, O.; Maruk, A.; Machulkin, A. Pharmacokinetic Properties of 68Ga-Labelled Folic Acid Conjugates: Improvement Using HEHE Tag. Molecules 2020, 25, 2712. [Google Scholar] [CrossRef]
- Yamashita, M.; Horii, H.; Hashiba, M.; Imahori, Y.; Mizukawa, N. The use of computed radiography for the determination of the impurities in 68Ga-EDTA by paper chromatography. Radioisotopes 1986, 35, 478–481. [Google Scholar] [CrossRef] [PubMed]
- Summary Product Characteristics for Galliapharm, Radionuclide Generator. Available online: https://produktresume.dk/AppBuilder/serach?q=Galliapharm%2C+radionuclide+generator+0.74-1.85+GBq.docx (accessed on 10 August 2022).
Reagent | Amount per EDTA Kit |
---|---|
Disodium EDTA dihydrate | 1.86 mg |
Sodium acetate trihydrate | 136 mg |
NaOH | 7.99 mg |
Sterile water | Up to 3.00 mL |
Test (Method) * | Specifications | EDTA Kit Batch 1 | EDTA Kit Batch 2 | EDTA Kit Batch 3 |
---|---|---|---|---|
pH (pH meter) | 12.0–13.0 | 12.4 | 12.3 | 12.4 |
Filter integrity (Manual) | Intact | Intact | Intact | Intact |
Sterility | No growth | No growth | No growth | No growth |
Volume (Visual) | 3.0 ± 0.5 mL | 3.0 | 3.0 | 3.0 |
Appearance (Visual) | Clear without particles | Clear without particles | Clear without particles | Clear without particles |
Identity (Fe-EDTA) (HPLC) | 2.5–3.5 min | 3.0 | 3.0 | 3.0 |
Na2EDTA·2H2O (HPLC) | 0.62 g/mL ± 20% (0.50–0.74 mg/mL) | 0.64 | 0.69 | 0.69 |
Labelling (full QC program) | Comply | Comply | Comply | Comply |
QC (Method) * | Specifications | [68Ga]Ga-EDTA Batch 1 | [68Ga]Ga-EDTA Batch 2 | [68Ga]Ga-EDTA Batch 3 |
---|---|---|---|---|
Radioactivity (dose calibrator) | ≤1373 MBq at EOS | 1363 | 1373 | 1329 |
Volume (visual) | 9.0–11.0 mL | 9.0 | 9.5 | 9.5 |
Appearance (visual) | Clear without particles | Clear without particles | Clear without particles | Clear without particles |
Filter integrity (manual) | Intact | Intact | Intact | Intact |
pH (indicator paper) | 4.0-6.0 | 4.7 | 4.7 | 4.7 |
68Ga-colloid (paper chromatography) | <3% | 0.3 | 0.3 | 0.2 |
RCP (paper chromatography) | >95% | 99.8 | 99.7 | 99.8 |
Identity (paper chromatography) | 0.7 < Rf < 1.3 | 1.1 | 1.0 | 1.1 |
Radionuclidic purity (Gamma counter) | <0.001% activity from 68Ge | <0.00001 | <0.00001 | <0.00001 |
Endotoxin (EndoSafe) | <17.5 EU/mL | <5.00 | <5.00 | <5.00 |
Sterility | No growth | No growth | No growth | No growth |
Entry | TLC System | 68Ga-Colloid | [68Ga]Ga-EDTA |
---|---|---|---|
1 | SP: iTLC-SG MP: 77 g/L NH4OAc(aq)/MeOH (1/1) 68Ga-colloid: Ph.Eur. Reference: [21] | ||
2 | SP: iTLC-SG MP: 0.1M EDTA in 0.25 M NH4Ac, pH 5.5 68Ga-colloid: Ph.Eur. Reference: [24] | ||
3 | SP: iTLC-SG MP: TFA 4% 68Ga-colloid: Ph.Eur. Reference: [25] | ||
4 | SP: iTLC-SG MP: 0.9% NaCl/MeCN (1/1) + 0.08% TFA 68Ga-colloid: Bench titration Reference: [26] | ||
5 | SP: Whatman Grade 1CHR MP: Water/ethanol/pyridine (4/2/1) 68Ga-colloid: Ph.Eur. Reference: [23,27] |
Entry | TLC System | 68Ga-Colloid | [68Ga]Ga-EDTA |
---|---|---|---|
1 | SP: iTLC-SG MP: HCl pH 5.6 68Ga-colloid: Bench titration | ||
2 | SP: Whatman Grade 1CHR MP: HCl pH 5.6 68Ga-colloid: Bench titration | ||
3 | SP: Whatman Grade 1CHR MP: 0.9% NaCl 68Ga-colloid: Bench titration |
Reagent | Molar Weight (g/mol) | Amount of Substance (mol) | Mass (g) |
Volume (mL) |
---|---|---|---|---|
Disodium EDTA dihydrate | 372.24 | 0.000167 | 0.0620 | - |
Sodium acetate trihydrate | 136.08 | 0.0333 | 4.54 | - |
NaOH (3 M) | - | 0.00666 | - | 2.22 |
Sterile water | - | - | - | Up to 100 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Skulska, M.; Falborg, L. A Simple Kit for the Good-Manufacturing-Practice Production of [68Ga]Ga-EDTA. Molecules 2023, 28, 6131. https://doi.org/10.3390/molecules28166131
Skulska M, Falborg L. A Simple Kit for the Good-Manufacturing-Practice Production of [68Ga]Ga-EDTA. Molecules. 2023; 28(16):6131. https://doi.org/10.3390/molecules28166131
Chicago/Turabian StyleSkulska, Monika, and Lise Falborg. 2023. "A Simple Kit for the Good-Manufacturing-Practice Production of [68Ga]Ga-EDTA" Molecules 28, no. 16: 6131. https://doi.org/10.3390/molecules28166131
APA StyleSkulska, M., & Falborg, L. (2023). A Simple Kit for the Good-Manufacturing-Practice Production of [68Ga]Ga-EDTA. Molecules, 28(16), 6131. https://doi.org/10.3390/molecules28166131